NCT06679803Active, not recruiting
Feasibility of a First-Line Physical Activity Intervention After Stroke
PA-ChatS: Feasibility of Delivering a First-Line Physical Activity Intervention After Stroke
Source: ClinicalTrials.gov · Last updated 10 Sept 2026
Brief summary (registry, in English)
The goal of this study is to explore a new intervention that supports physical activity within the first 6 weeks after stroke. All participants will complete assessments at weeks 0 and 7. During weeks 1 through 6, participants will use a Fitbit Inspire to track their step counts and meet with an occupational therapist one time per week. They will also complete weekly surveys. Physical activity levels will be measured using surveys and a wearable activPAL monitor 6 times during the study: Weeks 1, 3, 5, 7, 12, and 24.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 21 (actual)
- First submitted
- 5 Nov 2024
- Start date
- 5 Feb 2025
- Primary completion date
- 22 Jul 2026
- Lead sponsor
- University of Minnesota
- Diseases
- Stroke
- NCT number
- NCT06679803
What you commit to
- Study type: Interventional
- Participants enrolled: 21
- From 5 Feb 2025 to the primary completion date, 22 Jul 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Received inpatient treatment or was hospitalized for psychiatric condition and/or alcohol or substance abuse within the past 12 months
- Current diagnosis of a terimnal illness and/or receiving hospice care
- Concurrent participation in another rehabilitation intervention research study
Other illness
- Comorbid neurological disorder (Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis, myasthenia gravis, dementia, Alzheimer's disease, Huntington's disease, glioblastoma, spinal cord injury, cerebral palsy)
- Comorbid cancer, currently undergoing chemotherapy or radiation treatment
- History of allergic reaction to adhesives that precludes the use of an adhesive necessary for adherence to activPAL measurement
Other
- Discharge anticipated to a transitional care unit, skilled nursing facility, or other non-community-based care setting
- Severe cognitive or communication impairments (inability to respond accurately to complete study screening questions or to provide informed consent or assent
- Inability to speak, read, or understand English
- Resides more than 50 miles outside of the Twin Cities metropolitan area
- Investigator discretion for safety or adherence reasons
Who the study is looking for
- Stroke diagnosis confirmed by imaging
- Admitted to Fairview Health System (Minnesota) at the time of study enrollment or discharged to a community-based setting from Fairview Health System within 3 months before study enrollment
- Able and willing to participate fully in the study and provide informed consent or proxy consent with participant assent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Minnesota Coordinator of this site? Confirm its status | Minneapolis | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.